Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Acutus Medical, Inc.

Acutus Medical provides medical technology focused on the diagnosis and treatment of cardiac arrhythmias, including personalized ablation strategies aimed at improving patient outcomes.

Acutus Medical

Acutus Medical, Inc. | 17,512 followers on LinkedIn. Leading The Charge™️ | Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies that provide physicians and patients with improved results.

AcQMap, AcQRef and AcQGuide devices are CE Marked and FDA cleared. Please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.

Willem G. Jansen

Commercial Leader/ Board Member

Niamh Pellegrini

Program Director at Acutus Medical, Inc.

Victor Culafic

Experienced I.T. Professional | Sr. Desktop Support | Technical Support

Sater K

300 AcQMap cases and counting! Congratulations to Dr. Betts and his team for reaching this significant milestone. We look forward to the next 300!

Congratulations to St. Jude Fullerton and Dr. Brian Kim on reaching a remarkable milestone this week—400 Acutus cases and counting! Thank you to the St. Jude Fullerton team—and especially Dr. Kim—for leveraging the AcQMap system to benefit your patients. Please join us in celebrating the team’s remarkable achievement.

AcQMap offers a valuable advantage no other system can duplicate. By visualizing the whole chamber and identifying the source of a patient’s arrhythmia, it is possible to target the substrate driving a patient’s unique disease and achieve superior outcomes even in the most challenging patient populations. Drop a 👋 below to discover how you can leverage AcQMap in your practice.

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	2.17M -	2.84M 30.93%	8.46M 198.45%	17.26M 103.96%	16.36M 5.21%	3.03M 81.48%
cost of revenue	7.51M -	9.24M 23.08%	15.89M 71.90%	32.92M 107.22%	31.91M 3.08%
gross profit	-5.34M -	-6.41M 19.89%	-7.42M 15.89%	-15.66M 110.94%	-15.55M 0.73%	3.03M 119.50%
selling and marketing expenses	13.33M -	26.85M 101.40%
general and administrative expenses	13.33M -	26.85M 101.40%
selling general and administrative expenses	13.33M -	26.85M 101.40%	50.36M 87.57%	63.52M 26.15%	47.65M 24.98%	20.32M 57.37%
research and development expenses	19.08M -	38.03M 99.34%	33.45M 12.03%	36.68M 9.65%	28.15M 23.25%	3.12M 88.92%
other expenses			97K -
cost and expenses	39.92M -	74.12M 85.68%	99.70M 34.51%	133.13M 33.53%	107.72M 19.09%	23.43M 78.25%
operating expenses	32.41M -	64.88M 100.19%	83.81M 29.19%	100.21M 19.56%	75.81M 24.35%	23.43M 69.09%
interest expense	5.23M -	22.27M 325.69%	5.51M 75.27%	5.68M 3.11%	5.15M 9.30%	-5.15M 200%
ebitda	-36.26M -	-66.95M 84.66%	-86.90M 29.79%	-108.86M 25.28%	-83.36M 23.43%	41.04M 149.24%
operating income	-37.75M -	-72.57M 92.23%	-91.33M 25.86%	-112.12M 22.76%	-27.34M 75.62%	41.04M 250.13%
depreciation and amortization	2.12M -	5.62M 164.83%	4.44M 21.01%	3.26M 26.53%	-56.02M 1,818.34%
total other income expenses net	-4.30M -	-24.47M 469.33%	-10.63M 56.58%	-5.56M 47.66%	-12.20M 119.30%	-12.20M 0%
income before tax	-47.91M -	-97.04M 102.56%	-101.96M 5.07%	-117.68M 15.42%	-39.53M 66.41%	28.85M 172.97%
income tax expense	-4.92M -	22.27M 552.14%	23K 99.90%	5.68M 24,582.61%	82K 98.56%	15K 81.71%
net income	-47.91M -	-119.31M 149.04%	-101.98M 14.52%	-123.36M 20.96%	-39.62M 67.89%	28.83M 172.78%
weighted average shs out	16.85M -	17.27M 2.50%	11.41M 33.96%	28.65M 151.19%	28.32M 1.16%
weighted average shs out dil	16.85M -	17.27M 2.50%	11.41M 33.96%	28.65M 151.19%	28.32M 1.16%
eps	-2.84 -	-6.91 143.31%	-8.94 29.38%	-4.31 51.79%	-1.40 67.52%	-1.40 0%
epsdiluted	-2.84 -	-6.91 143.31%	-8.94 29.38%	-4.31 51.79%	-1.40 67.52%	-1.40 0%

COM:ACUTUSMEDICAL

Acutus Medical

Last Close

0.06

22/11 20:00

Market Cap

832.20K

Beta: -

Volume Today

44.46K

Avg: -

Preview